Identification of New Biomarkers of Low-Dose GH Replacement Therapy in GH-Deficient Patients

CONTEXT: GH secretion peaks at puberty and continues to be secreted in adulthood, albeit at a declining rate. Profound GH deficiency (GHD) in adults with pituitary disease is associated with symptoms that improve with GH substitution, but it is important to tailor the GH dose to avoid overtreatment....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Cruz-Topete, Diana, Jorgensen, Jens Otto L., Christensen, Britt, Sackmann-Sala, Lucila, Krusenstjerna-Hafstrøm, Thomas, Jara, Adam, Okada, Shigeru, Kopchick, John J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Endocrine Society 2011
Soggetti:
Endocrine Care
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3205513/
https://ncbi.nlm.nih.gov/pubmed/21543428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2011-0197
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi